Veldt, A.A.M. van der

sunitinib patient cancer polymorphism hypertension treatment factor study sunitinib treatment analysis haplotype survival grade 3 hypertension metastatic therapy association multivariate blood center presence cell carcinoma abcb 1 haplotype tumor vegfr grade pressure outcome number cycle level pharmacokinetic carcinoma mrcc patients cell cancer disease change cyp 3a mskcc oncol tcg copy department research baseline progression-free survival metastatic sites group characteristic analyses vegfa month mskcc risk factors vegfr -2 netherland article cancer research treatment cycle diastolic blood pressure result acg haplotype nr 1i haplotype pharmacodynamic transporter blood pressure table abcb 1 university multivariate analyses exposure prognostic systolic blood pressure criteria cyp 3a 6986 a-allele prognostic criteria cat copy abcg 2 sunitinib therapy growth oncology onlinefirst